Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price fell 23.8% on Tuesday . The stock traded as low as GBX 15.21 ($0.21) and last traded at GBX 16 ($0.22). 130,612 shares were traded during trading, an increase of 122% from the average session volume of 58,894 shares. The stock had previously closed at GBX 21 ($0.28).
Tissue Regenix Group Price Performance
The firm has a market cap of £7.84 million, a PE ratio of -1,100.00 and a beta of 1.61. The firm’s fifty day simple moving average is GBX 28.17 and its two-hundred day simple moving average is GBX 31.37. The company has a quick ratio of 2.36, a current ratio of 4.03 and a debt-to-equity ratio of 31.16.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Recommended Stories
- Five stocks we like better than Tissue Regenix Group
- How to Calculate Options Profits
- Datavault AI: The New AI Contender Backed by Big Funding
- How to Use the MarketBeat Dividend Calculator
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
